ProteoWise
Branford
About ProteoWise
ProteoWise’s technology provides a unique combination of high information content, high throughput, and low cost - all while simplifying the western blot dramatically. This combination is what’s driving the genomic revolution and is needed for proteomics. ProteoWise is founded by a seasoned team of scientists from the Strittmatter Lab at Yale University with a history of innovation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.9M
- Last round: Series Unknown (Apr 2021)
- Website: proteowise.com
- Phone: 203-430-4187
Industries & Categories
Biotechnology, Medical, Wellness
Canonical: https://fsome.com/organization/proteowise-78975 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.